Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review".

Organisation Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
Products Product in vitro diagnostics (IVD)
  Product 2 molecular diagnostics
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Strong sales dynamic confirmed in second quarter, leading to sales up 10.4% over the first half at constant exchange rates and scope of consolidation:

>> €1,169 million in sales

>> Up 3.1% as reported

> Growth driven by robust molecular biology and microbiology lines and by industrial applications.

Alexandre Mérieux, Chairman and Chief Executive Officer, said: “After a first quarter in which sales were particularly high due to the flu season, the second quarter of 2018 was another period of strong sales performance for bioMérieux with organic growth of 8.4%. The Group’s balanced and diversified geographic footprint and its comprehensive offering based on three key technologies of in vitro diagnostics were major factors in its success in the second quarter.”

[ Full Release at ]

Record changed: 2018-08-22


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for Mérieux (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top